KOSDAQ · 018680 · Biotech & Pharma · ₩018680

Seoul Pharma서울제약

018680 · KOSDAQ · ₩018680 · 서울제약

₩1,691▼ ₩91 (5.11%)End-of-day · Oct 30, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Aug 28, 2026Open on DART
Results of Extraordinary Shareholders' Meeting임시주주총회결과Aug 21, 2026Open on DART
Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Aug 14, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Aug 6, 2026Open on DART
Shareholders' meeting called주주총회소집결의Jul 9, 2026Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jul 9, 2026Open on DART
Disclosure of Large Business Group Status [Annual Disclosure and Q1 Use (Individual Companies)]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]Jun 1, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Apr 1, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
Audit report submitted감사보고서제출Mar 19, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 6, 2026Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Apr 18, 2025Open on DART
Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
Audit report submitted감사보고서제출Mar 20, 2025Open on DART
Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 17, 2025Open on DART
Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 13, 2025Open on DART
Shareholders' meeting called주주총회소집결의Mar 13, 2025Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 13, 2025Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 7, 2025Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 13, 2024Open on DART
Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
Quarterly report (Mar 2024)분기보고서 (2024.03)May 14, 2024Open on DART
Change of Department Affiliation소속부변경Apr 30, 2024Open on DART
Annual general meeting results정기주주총회결과Mar 28, 2024Open on DART
Audit report submitted감사보고서제출Mar 20, 2024Open on DART
Annual report (Dec 2023)사업보고서 (2023.12)Mar 20, 2024Open on DART
Shareholders' meeting called주주총회소집결의Mar 13, 2024Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 13, 2024Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 2, 2024Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 14, 2023Open on DART
Quarterly report (Sep 2023)분기보고서 (2023.09)Nov 14, 2023Open on DART
불성실공시법인미지정(지정유예)Aug 16, 2023Open on DART
Half-year report (Jun 2023)반기보고서 (2023.06)Aug 14, 2023Open on DART
불성실공시법인지정예고(공시번복)Jul 21, 2023Open on DART
Sales or supply contract terminated단일판매ㆍ공급계약해지Jun 22, 2023Open on DART
Quarterly report (Mar 2023)분기보고서 (2023.03)May 11, 2023Open on DART

Titles in Korean until English translations are added.

Also known as: Seoul Pharma / 서울제약 / 018680 / KRX:018680

Source: KRX statistical information